Nephroprotective strategies in septic shock: the VANISH trial
- PMID: 28066645
- PMCID: PMC5179465
- DOI: 10.21037/jtd.2016.11.44
Nephroprotective strategies in septic shock: the VANISH trial
Conflict of interest statement
The authors have no conflicts of interest to declare.
Comment on
-
Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.JAMA. 2016 Aug 2;316(5):509-18. doi: 10.1001/jama.2016.10485. JAMA. 2016. PMID: 27483065 Clinical Trial.
References
-
- Torio CM, Andrews RM. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011: Statistical Brief #160. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US) 2006-2013. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources